Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gallbladder Neoplasms × Immunohistochemistry × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 6 Rectal Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Colonic Neoplasms 5 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Follicular 4 Immunoblastic Lymphadenopathy 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Breast Neoplasms, Male 4 Sezary Syndrome 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Mantle-Cell 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Esophageal Neoplasms 3 Burkitt Lymphoma 3 Adenocarcinoma Of Esophagus 3 Waldenstrom Macroglobulinemia 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Gemcitabine 18 Cisplatin 10 Capecitabine 9 Oxaliplatin 6 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Erlotinib Hydrochloride 3 trifluridine tipiracil drug combination 2 regorafenib 2 cobimetinib 2 atezolizumab 2 Trastuzumab 2 Taxes 2 Specimen Handling 2 Platinum 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Lapatinib 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 varlilumab 1 vandetanib 1 tucatinib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡